Day: August 5, 2010

A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne

Valerie D. Callender, MD is from Callender Skin and Laser Center, Mitchellville, Maryland. Norman Preston, PhD; Cris Osborn, PhD; Lori Johnson, PhD; and Ronald W. Gottschalk, MD are from Galderma Laboratories, LP, Fort Worth, Texas Disclosure: Dr. Callender is a clinical researcher and consultant for Galderma. Drs. Preston, Osborn, Johnson, and Gottschalk are employed by


A Practical Approach to Monitoring Patients on Biological Agents for the Treatment of Psoriasis

Jason J. Emer, MD; Amylynne Frankel, MD; Joshua A. Zeichner, MD Mount Sinai School of Medicine, Department of Dermatology, New York, New York Disclosure: Drs. Emer and Frankel report no relevant conflicts of interest. Dr. Zeichner is an investigator for Centocor. Abstract Psoriasis is a chronic, systemic, inflammatory skin condition that manifests predominantly as well-demarcated,


Global Volumetric Assessment and Three-dimensional Enhancement of the Face With Injectable Poly-L-lactic Acid

Richard N. Sherman, MD Skin Institute of New Orleans, New Orleans, Louisiana; Clinical Associate Professor, Department of Dermatology, Tulane University, New Orleans, Louisiana Disclosure: Dr. Sherman is a speaker, master trainer, and advisory board member for Sanofi-Aventis U.S. LLC. Editorial support for this article was provided by the editorial staff at Embryon. This article was


A Second Case of Sunitinib-associated Pyoderma Gangrenosum

Steven M. Dean, DO, FACP, RPVI; Matthew Zirwas, MD The Ohio State University, Columbus, Ohio Disclosure: Drs. Dean and Zirwas report no relevant conflicts of interest. Abstract Pyoderma gangrenosum is a painful, noninfectious, ulcerative, cutaneous disorder that most commonly affects the lower extremities. The diagnosis is made by recognizing the characteristic clinical manifestations in the


Aesthetic Update: What’s New in Fillers in 2010?

Michael H. Gold, MD   Dr. Gold is the founder and medical director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser and Rejuvenation Center, and Tennessee Clinical Research Center located in Nashville, Tennessee. He is also Clinical Assistant Professor at Vanderbilt University School of Medicine and School of Nursing in Nashville, Tennessee;